7RQ-29010-94185
3 vaccinations
7 coded responses
29 check-ins
7 free-text entries
4 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 070 / NJ
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Moderna
-
2021-01-12
Registered in v-safe
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-24
-
2021-01-29
Survey response — day 21, dose 1MedDRA: Petechiae — Feeling: GoodFree text: Petechiae on palms and fingers (previous history)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Dose 2 — Moderna
- 2021-02-05
-
2021-02-12
Survey response — day 7, dose 2MedDRA: Chills, Pyrexia — Feeling: FairFree text: Had fever to 102, chills, rigors Feb 6 associated with 2nd dose Feb 5MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-26
- 2021-03-05
-
2021-03-12
Survey response — day 35, dose 2MedDRA: Venous thrombosis — Feeling: GoodFree text: Superficial vein thrombosisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-19
-
2021-05-09
Survey response — 3 months, dose 2MedDRA: Peyronie's disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with Peyronie's disease after 2nd dose, symptom onset between 1st and 2nd doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-06
Survey response — 6 months, dose 2MedDRA: Peyronie's disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Development of Peyronie's disease, between receipt of first and second vaccine dose. Diagnosis was delayed.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-06
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-14
- 2021-08-14
-
2021-11-30
Dose 3 — Moderna
-
2021-12-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-12-03
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-03-03
-
2022-05-31
Survey response — 6 months, dose 3MedDRA: Autonomic neuropathy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Autonomic neuropathy, unknown causeMedDRA releases: 2024-11 · check-in free text available
-
2022-05-31
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-01
- 2022-06-01
- 2022-06-01
-
2022-11-30
Survey response — 12 months, dose 3MedDRA: Cramp-fasciculation syndrome, Nervous system disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Diagnosed with cramp fasciculation syndrome (neurologic disorder)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-30
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-01
- 2022-12-01
- 2022-12-01
- 2022-12-01
- 2022-12-02
- 2022-12-02
- 2022-12-02
- 2022-12-02
-
2022-12-02
Callback requested for08:00AM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-05 | Moderna | |
| 3 | 2021-11-30 | Moderna | No |
Call center
4 call center cases
4 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — day 21, dose 1
Symptoms: Petechiae on palms and fingers (previous history)
Release 4 — day 7, dose 2
Systemic reaction (other): Had fever to 102, chills, rigors Feb 6 associated with 2nd dose Feb 5
Release 5 — day 35, dose 2
Symptoms: Superficial vein thrombosis
Release 8 — 3 months, dose 2
Symptoms: Diagnosed with Peyronie's disease after 2nd dose, symptom onset between 1st and 2nd dose
Release 9 — 6 months, dose 2
Symptoms: Development of Peyronie's disease, between receipt of first and second vaccine dose. Diagnosis was delayed.
Release 11 — 6 months, dose 3
Symptoms: Autonomic neuropathy, unknown cause
Release 12 — 12 months, dose 3
Symptoms: Diagnosed with cramp fasciculation syndrome (neurologic disorder)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Autonomic neuropathy | · | · | ✓ |
| SD | Cramp-fasciculation syndrome | · | · | ✓ |
| SD | Nervous system disorder | · | · | ✓ |
| SD | Petechiae | ✓ | ✓ | ✓ |
| SD | Peyronie's disease | ✓ | ✓ | ✓ |
| SD | Venous thrombosis | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release